Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:EthicsLegal UpdatesLegislation & AdvocacyResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

RheumPAC Supports Two Candidates Who Support Rheumatology

Staff  |  November 1, 2009

RheumPAC, the ACR’s political action committee (PAC), ensures that the ACR is involved in healthcare reform discussions. RheumPAC representatives have been busy attending fundraisers and educating key congressional members on the ACR’s legislative priorities.

Your Patients Can Make a Difference—Get Them Involved with Advocacy!

Staff  |  November 1, 2009

Personal stories are the most effective way to communicate an issue to Congress. No one can better illustrate the complex nature of healthcare policy decisions and how they affect medical care than those involved daily in the medical profession.

Within Our Reach–Funded Research May Hold Key to Unlocking the CNS and Suppressing RA

Staff  |  November 1, 2009

Studies recently published in Arthritis & Rheumatism show that a key chemical produced by the central nervous system (CNS) decreases inflammation and suppresses production of proteins known to play a role in rheumatoid arthritis (RA). This opens the way for developing a novel class of drugs that mimic this effect of the CNS on RA.

Pharmaceutical Tourism

Bruce N. Cronstein, MD  |  November 1, 2009

Could trade agreements and not bulky legislation be the key to cheaper drugs?

The Canes of York

David S. Pisetsky, MD, PhD  |  November 1, 2009

What can a walking stick tell us about U.S. healthcare?

The Health Buzz

Stanley B. Cohen, MD  |  November 1, 2009

What is the ACR doing with healthcare reform?

Another Vocabulary for Rheumatology Research

Gretchen Henkel  |  October 1, 2009

Matt Liang, MD, MPH, addresses patients’ authentic concerns

Reading Rheum

Gail C. Davis, RN, EdD; Michael M. Ward, MD;  |  October 1, 2009

Handpicked Reviews of Contemporary Literature

Stimulus Package Creates Flurry of Research Funds

Kurt Ullman  |  October 1, 2009

Researchers celebrate boon, but wonder what will happen next

What Has RheumPAC Done for You Lately?

Staff  |  October 1, 2009

RheumPAC, the ACR’s political action committee, is dedicated to ensuring that rheumatology issues are addressed in healthcare reform. The best way to make sure the issues affecting rheumatology are being heard is to engage in the discussions and to contribute to congressional campaigns.

  • « Previous Page
  • 1
  • …
  • 223
  • 224
  • 225
  • 226
  • 227
  • …
  • 246
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences